Compound Angiotrophic Biphasic Myeloid Sarcoma with JAK2 (V617F) and KRAS (G12C) mutations
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
165 3
Ultima descărcare din IBN:
2024-03-29 22:19
Căutarea după subiecte
similare conform CZU
616-006.446.8 (1)
Патология. Клиническая медицина (6988)
SM ISO690:2012
ABUKHIRAN, Ibrahim, ROSENTHAL, Nancy, SÎRBU, Serghei. Compound Angiotrophic Biphasic Myeloid Sarcoma with JAK2 (V617F) and KRAS (G12C) mutations. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2023, vol. 10, nr. 4, pp. 78-80. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2023.4.10
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista de Ştiinţe ale Sănătăţii din Moldova
Volumul 10, Numărul 4 / 2023 / ISSN 2345-1467

Compound Angiotrophic Biphasic Myeloid Sarcoma with JAK2 (V617F) and KRAS (G12C) mutations

DOI:https://doi.org/10.52645/MJHS.2023.4.10
CZU: 616-006.446.8

Pag. 78-80

Abukhiran Ibrahim1, Rosenthal Nancy2, Sîrbu Serghei3
 
1 University of Pittsburgh,
2 Wake Forest School of Medicine, Winston Salem,
3 University of Iowa Hospitals and Clinics, Iowa
 
 
Disponibil în IBN: 15 decembrie 2023


Rezumat

Introduction. Myeloid sarcomas (MS) are extramedullary manifestations of myeloid neoplasms, associated with conditions like acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). MS presents as tumor masses in various body sites, often expressing myeloid or monocytic markers. This case report details an unusual biphasic MS relapse with a significant “intravascular” component. Materials and methods. A 59-year-old male with a history of JAK2-V617F positive MDS/MPN underwent allogeneic hematopoietic stem cell transplantation and presented with abdominal pain, skin lesions, and systemic symptoms. Biopsy of colonic masses was performed, and subsequent analysis was carried out. Results. The biopsy revealed a neoplasm with solid and intravascular components. The solid part was mainly composed of monocytic lineage cells expressing specific markers, with a small population of myeloid blasts. In contrast, the “intravascular” component was mainly myeloid blasts expressing different markers. Genetic analysis uncovered JAK2 (V617F) and KRAS (G12C) mutations. Despite treatment, the disease progressed, and the patient eventually passed away. Conclusions. Myeloid sarcomas are challenging to diagnose, often being mistaken for large cell lymphomas. They can manifest as isolated extramedullary relapses, with a unique molecular profile. This case stands out due to its biphasic nature, featuring distinct components with differing characteristics, which has not been documented previously in English literature. It underscores the intricate and diverse nature of myeloid sarcomas, emphasizing the need for further research to comprehend their biology and behavior effectively.

Cuvinte-cheie
compound, Angiotrophic, Biphasic, myeloid sarcoma, JAK2, V617F, KRAS, G12C, AML, acute myeloid leukemia, myelodysplastic syndrome, Mds, myeloproliferative neoplasm, MPN